List of Excipients in Branded Drug SODIUM SULFACETAMIDE

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Oceanside Pharmaceuticals	SODIUM SULFACETAMIDE	sodium sulfacetamide	68682-010	EDETIC ACID
Oceanside Pharmaceuticals	SODIUM SULFACETAMIDE	sodium sulfacetamide	68682-010	HYDROXYETHYL CELLULOSE
Oceanside Pharmaceuticals	SODIUM SULFACETAMIDE	sodium sulfacetamide	68682-010	LAURIC DIETHANOLAMIDE
Oceanside Pharmaceuticals	SODIUM SULFACETAMIDE	sodium sulfacetamide	68682-010	METHYLPARABEN
Oceanside Pharmaceuticals	SODIUM SULFACETAMIDE	sodium sulfacetamide	68682-010	POLYETHYLENE GLYCOL 400
Oceanside Pharmaceuticals	SODIUM SULFACETAMIDE	sodium sulfacetamide	68682-010	SODIUM CHLORIDE
Oceanside Pharmaceuticals	SODIUM SULFACETAMIDE	sodium sulfacetamide	68682-010	SODIUM METABISULFITE

Excipient Strategy and Commercial Opportunities for Sodium Sulfacetamide

Last updated: February 27, 2026

What is Sodium Sulfacetamide?

Sodium sulfacetamide is a topical or ophthalmic sulfonamide antibiotic used primarily in the treatment of bacterial infections. It inhibits bacterial synthesis of folic acid, disrupting DNA replication. The drug is available in formulations such as solutions, creams, and ointments, often combined with other agents.

Excipient Strategy for Sodium Sulfacetamide

Key Considerations

The excipient profile significantly impacts drug stability, delivery, and patient compliance. For sodium sulfacetamide formulations, excipient selection follows these priorities:

• Solubility and Stability: Enhancing solubility in aqueous solutions is critical, especially for ophthalmic and topical formulations.
• pH Control: Maintaining pH between 4.0 and 6.0 stabilizes the drug and optimizes bioavailability.
• Preservatives: Benzalkonium chloride or chlorobutanol are common in ophthalmic solutions, ensuring microbial stability.
• Humectants: Glycerin or propylene glycol improve moisture retention in topical creams or gels.
• Chelating Agents: EDTA stabilizes the formulation by chelating metal ions that catalyze decomposition.

Common Excipients in Formulations

Ingredient	Function	Rationale
Benzalkonium chloride	Preservative	Effective against bacteria and fungi
Glycerin	Humectant	Prevents dehydration of the formulation
Sodium chloride	Osmotic regulator	Equalizes osmotic pressure, especially in ophthalmics
Boric acid	pH buffer, preservative	Maintains stability and pH control
Propylene glycol	Solvent, humectant	Enhances solubility and moisture retention

The selection of excipients also considers compatibility with sodium sulfacetamide, minimizing degradation or precipitation over shelf life.

Formulation Strategies

• Aqueous solutions for ophthalmic use incorporate preservatives, buffering agents, and stabilizers.
• Topical creams and ointments include bases such as petrolatum or aqueous gels with humectants.
• Combination formulations pair sodium sulfacetamide with other antimicrobials or anti-inflammatory compounds.

Market and Commercial Opportunities

Growth Drivers

• Increased Incidence of Bacterial Skin Infections: Rising rates of acne, rosacea, and blepharitis drive demand.
• Local Delivery Preference: Topical and ophthalmic formulations are favored over systemic antibiotics due to lower side effects.
• Generic Competition: Many formulators produce sodium sulfacetamide formulations, providing accessible pricing but limiting premium opportunities.

Strategic Opportunities

• Novel Formulations: Liposomal or nanocarrier systems could improve drug penetration and reduce dosing frequency.
• Combination Products: Fixed-dose combinations with other antibiotics or anti-inflammatory agents could expand indications.
• Differentiated Delivery: Ocular gels or sustained-release topical patches provide convenience, targeting niche segments.
• Regulatory Incentives: Developing preservative-free or preservative-limited formulations in response to patient sensitivities.

Market Data and Forecast

• The global ophthalmic antibiotics market is projected to grow at a CAGR of approximately 4.2% from 2022 to 2028, driven by inflammatory eye conditions treated with sulfacetamide-based formulations [1].
• The topical antimicrobial market segments expand with emerging dermatological needs, including treatment-resistant acne and bacterial dermatitis.

Challenges

• Formulation Stability: Maintaining efficacy amid various excipient interactions.
• Patent Landscape: Limited patent protection for sodium sulfacetamide drugs, influencing pricing strategies.
• Regulatory hurdles: Ensuring compliance with preservative and stability standards, especially in preservative-free formulations.

Key Takeaways

• Excipient selection for sodium sulfacetamide focuses on stability, solubility, and patient acceptance.
• Preservatives, pH buffers, and humectants dominate formulation strategies.
• Commercial opportunities lie in novel delivery systems, combination therapies, and specialty formulations.
• Market growth is driven by increased skin and eye infection prevalence, with competition mainly from generics.

FAQs

1. What excipients are essential in sodium sulfacetamide ophthalmic solutions?
Preservatives such as benzalkonium chloride, buffers to maintain pH, and stabilizers like EDTA are essential.

2. How can formulations improve patient compliance?
Using preservative-free options, sustained-release systems, or combination products can enhance adherence.

3. What are the regulatory challenges for new sodium sulfacetamide formulations?
Regulatory requirements include demonstrating stability, compatibility, and safety, particularly for preservative-free designs.

4. Is there potential for new delivery systems?
Yes. Liposomal, nanoparticle, or sustained-release patches can improve drug efficacy and convenience.

5. How does excipient choice influence drug stability?
Excipients can interact with the active ingredient, affecting solubility, pH stability, and shelf life.

---

References

[1] MarketsandMarkets. (2022). Ophthalmic antibiotics market forecast.